Internal Medicine, Endocrinology, Diabetes, & Metabolism · Providence, RI
NPI
1407995640
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
100 Highland Ave
Providence, RI, 02906
Phone (401) 351-7100
Groups this clinician bills Medicare through
Medicare paid, 2024
$189K
8,406 services
Medicare patients, 2024
619
Average age 74
Drug cost, 2024
$3.7M
12,307 prescriptions
Company payments, 2025
$126
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roberto Ortiz was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 920 times for 466 patients. In total Roberto Ortiz billed 8,406 services in 43 codes, and Medicare paid $189K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 920 | 466 | $12.67 | $12K |
| 36415 Venipuncture Blood Collection | Office | 910 | 510 | $8.63 | $7,855 |
| 99214 Office E&M - Established | Office | 787 | 383 | $90.15 | $71K |
| 80053 Clinical Chemistry | Office | 732 | 380 | $10.35 | $7,576 |
| 83036 Blood Count | Office | 683 | 330 | $9.50 | $6,485 |
| 84443 Clinical Chemistry | Office | 628 | 403 | $16.44 | $10K |
| 80061 Clinical Chemistry | Office | 620 | 312 | $13.08 | $8,111 |
| 83721 Clinical Chemistry | Office | 619 | 312 | $10.26 | $6,351 |
| 84439 Clinical Chemistry | Office | 524 | 328 | $8.81 | $4,616 |
| 84481 Clinical Chemistry | Office | 463 | 305 | $16.54 | $7,656 |
| 99213 Office E&M - Established | Office | 314 | 242 | $62.08 | $19K |
| 82306 Clinical Chemistry | Office | 194 | 129 | $29.01 | $5,628 |
| 82570 Clinical Chemistry | Office | 184 | 144 | $5.06 | $930 |
| 82043 Clinical Chemistry | Office | 184 | 144 | $5.63 | $1,036 |
| 86800 Immunoassay | Office | 94 | 67 | $15.59 | $1,465 |
By year: 2022 $170K for 7,400 services; 2023 $179K for 7,646 services; 2024 $189K for 8,406 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 910 | 510 | $8.63 | $7,855 |
| 80053 Clinical Chemistry | 732 | 380 | $10.35 | $7,576 |
| 83036 Blood Count | 683 | 330 | $9.50 | $6,485 |
| 84443 Clinical Chemistry | 628 | 403 | $16.44 | $10K |
| 80061 Clinical Chemistry | 620 | 312 | $13.08 | $8,111 |
| 83721 Clinical Chemistry | 619 | 312 | $10.26 | $6,351 |
| 84439 Clinical Chemistry | 524 | 328 | $8.81 | $4,616 |
| 84481 Clinical Chemistry | 463 | 305 | $16.54 | $7,656 |
| 82306 Clinical Chemistry | 194 | 129 | $29.01 | $5,628 |
| 82043 Clinical Chemistry | 184 | 144 | $5.63 | $1,036 |
Medicare prescription drug claims, 2024
In 2024, the drug Roberto Ortiz prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,880 prescriptions and refills. In total Roberto Ortiz wrote 12,307 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,880 | 4,489 | 416 | $22K |
| Synthroid Levothyroxine Sodium | 698 | 1,503 | 145 | $58K |
| Glimepiride Generic | 697 | 1,805 | 186 | $9,102 |
| Metformin Hcl Er Metformin Hcl | 539 | 1,489 | 152 | $6,618 |
| Jardiance Empagliflozin | 535 | 882 | 109 | $505K |
| Atorvastatin Calcium Generic | 519 | 1,285 | 139 | $5,900 |
| Metformin Hcl Generic | 509 | 1,328 | 137 | $5,274 |
| Rosuvastatin Calcium Generic | 413 | 947 | 105 | $5,997 |
| Ozempic Semaglutide | 408 | 533 | 77 | $489K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 276 | 590 | 86 | $24K |
| Januvia Sitagliptin Phosphate | 263 | 515 | 62 | $274K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 252 | 583 | 86 | $50K |
| Methimazole Generic | 231 | 513 | 47 | $1,846 |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 199 | 370 | 45 | $99K |
| Lisinopril Generic | 174 | 459 | 48 | $1,730 |
Brand drugs: 4,963 claims; generic drugs: 6,492 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roberto Ortiz $126 ($126 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbvie Inc. with $57.3.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.